Characterization of the Cytosolic Tuberin-Hamartin Complex

Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by a broad phenotypic spectrum that includes seizures, mental retardation, renal dysfunction and dermatological abnormalities. Mutations to either the TSC1 orTSC2 gene are responsible for the disease. TheTSC1 gene encodes hamartin, a 130-kDa protein without significant homology to other known mammalian proteins. Analysis of the amino acid sequence of tuberin, the 200-kDa product of theTSC2 gene, identified a region with limited homology to GTPase-activating proteins. Previously, we demonstrated direct binding between tuberin and hamartin. Here we investigate this interaction in more detail. We show that the complex is predominantly cytosolic and may contain additional, as yet uncharacterized components alongside tuberin and hamartin. Furthermore, because oligomerization of the hamartin carboxyl-terminal coiled coil domain was inhibited by the presence of tuberin, we propose that tuberin acts as a chaperone, preventing hamartin self-aggregation.

[1]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[3]  Max F. Perutz,et al.  Glutamine repeats and neurodegenerative diseases: molecular aspects. , 1999, Trends in biochemical sciences.

[4]  E. Henske,et al.  Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. , 1998, Cancer research.

[5]  H. Onda,et al.  Tuberous Sclerosis Gene 2 Product Modulates Transcription Mediated by Steroid Hormone Receptor Family Members* , 1998, The Journal of Biological Chemistry.

[6]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.

[7]  M. Hengstschläger,et al.  A role of the tuberous sclerosis gene-2 product during neuronal differentiation , 1998, Oncogene.

[8]  J. Declue,et al.  Role of the Tuberous Sclerosis Gene-2 Product in Cell Cycle Control , 1997, The Journal of Biological Chemistry.

[9]  I. Hariharan,et al.  Biological characterization of Drosophila Rapgap1, a GTPase activating protein for Rap1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Snell,et al.  Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. , 1997, Human molecular genetics.

[11]  N. Minato,et al.  Human SPA-1 Gene Product Selectively Expressed in Lymphoid Tissues Is a Specific GTPase-activating Protein for Rap1 and Rap2 , 1997, The Journal of Biological Chemistry.

[12]  S Povey,et al.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.

[13]  E. Golemis,et al.  The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.

[14]  J. Bonifacino,et al.  Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. , 1996, Oncogene.

[15]  O. Hino,et al.  Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. , 1996, Cancer research.

[16]  M. Zerial,et al.  Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion , 1995, Cell.

[17]  J. Declue,et al.  Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.

[18]  P. Harris,et al.  The molecular genetics of tuberous sclerosis. , 1994, Human molecular genetics.

[19]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[20]  A Helenius,et al.  Folding of influenza hemagglutinin in the endoplasmic reticulum , 1991, The Journal of cell biology.

[21]  B. Oostra,et al.  Human lysosomal alpha-glucosidase. Characterization of the catalytic site. , 1991, The Journal of biological chemistry.

[22]  A. Lupas,et al.  Predicting coiled coils from protein sequences , 1991, Science.

[23]  Z. D. Sharp,et al.  A general method for polyethylene-glycol-induced genetic transformation of bacteria and yeast. , 1983, Gene.

[24]  D. Kwiatkowski,et al.  Tuberous sclerosis. , 1994, Archives of dermatology.

[25]  K. S. Fuiks,et al.  Tuberous sclerosis (2nd ed.) , 1989 .